Canopy Growth (CGC) News
Latest news and analysis
Canopy Growth Rally Lifts Cannabis Sector as ETF Tracks Recovery
CGC surge sparks broader cannabis stock momentum as institutional money flows back into beaten-down sector through ETF vehicles
Canopy Growth CEO Mongeau Drives Operational Overhaul Amid Market Pressure
CGC stock faces continued volatility as leadership implements cost-cutting measures and strategic pivots following years of underperformance in cannabis sector.
Canopy Growth Medical Push Drives Investor Interest Amid Sector Struggles
CGC stock gains attention as company expands medical cannabis operations while broader cannabis sector faces headwinds from regulatory delays and market pressures.
CGC Stock Draws Institutional Focus as Cannabis Sector Faces Volatility
Canopy Growth attracts heightened institutional attention as cannabis markets navigate regulatory uncertainty and sector-wide consolidation pressures.
Canopy Growth Eyes German Cannabis Market as Legalization Unfolds
CGC explores European expansion opportunities as Germany's recreational cannabis framework takes shape, potentially opening new revenue streams.
Canopy Growth Surges on German Cannabis Market Re-Entry Strategy
CGC stock climbs as the cannabis giant repositions for Germany's evolving recreational market following recent regulatory shifts.
Canopy Growth Launches New Softgel Products to Capture Premium Market
CGC expands its softgel lineup with innovative formats targeting higher-margin consumer segments as the company seeks revenue diversification.
CGC Debt Restructure Delays Inevitable Reckoning
Canopy Growth's latest financing moves provide temporary relief but fail to address fundamental operational challenges plaguing the cannabis giant.
Canopy Growth Charts EBITDA Recovery in Q4 Earnings Call
CGC management outlines profitability pathway as cannabis giant works to stabilize operations amid sector-wide margin pressure and regulatory headwinds.
Canopy Growth's Five-Year Outlook: Recovery Path or Continued Decline?
CGC faces mounting pressure as losses persist and market share erodes. Can the cannabis giant execute a turnaround by 2029?
Canopy Growth's Risk Profile Deteriorates as Losses Mount
Once a cannabis sector darling, CGC faces mounting financial pressures and operational challenges that have transformed it into a high-risk investment proposition.
Canopy Growth Posts $155M Loss, Forces Financial Restatements
Cannabis giant's latest earnings reveal continued struggles with $154.7M net loss and accounting irregularities requiring historical corrections.
Canopy Growth Revenue Trajectory Points to FY2026 Recovery Momentum
CGC shows early signs of stabilization as Canadian cannabis leader works through operational restructuring while retail expansion continues across key markets.
Canopy Growth Revenue Drops to C$284.6M as Cannabis Giant Struggles
Canopy Growth's fiscal 2026 results show continued revenue decline with C$284.6M annual sales and C$71.2M Q4, highlighting ongoing challenges in cannabis markets.
Canopy Growth Charts Path to Profitability with 2027 EBITDA Target
CGC reduces cash burn while setting ambitious timeline for adjusted EBITDA breakeven as cannabis giant restructures operations.
Canopy Growth Earnings Preview: Cannabis Giant Faces Critical Quarter
CGC reports quarterly results amid sector volatility and restructuring efforts. Investors watch for revenue trends and path to profitability signals.
Canopy Growth Q3 Preview: Cost Cuts Face Revenue Decline Reality
CGC reports Q3 results amid ongoing restructuring efforts, but shrinking cannabis markets test turnaround strategy effectiveness in competitive landscape.